Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-105085
Filing Date
2021-08-13
Accepted
2021-08-13 16:08:39
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 1341149
2 EXHIBIT 31.1 tmb-20210630xex31d1.htm EX-31.1 14455
3 EXHIBIT 31.2 tmb-20210630xex31d2.htm EX-31.2 18237
4 EXHIBIT 32.1 tmb-20210630xex32d1.htm EX-32.1 13109
  Complete submission text file 0001104659-21-105085.txt   5751279

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210630.xsd EX-101.SCH 42171
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20210630_cal.xml EX-101.CAL 53960
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210630_def.xml EX-101.DEF 106490
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210630_lab.xml EX-101.LAB 405088
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210630_pre.xml EX-101.PRE 283945
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 1025655
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 211172163
SIC: 2834 Pharmaceutical Preparations